D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 70 Citations 22,896 279 World Ranking 16107 National Ranking 585

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Diabetes mellitus
  • Type 2 diabetes

The scientist’s investigation covers issues in Internal medicine, Diabetes mellitus, Endocrinology, Type 2 diabetes and Insulin. His Diabetes mellitus study combines topics from a wide range of disciplines, such as Disease and Pneumonia. His studies deal with areas such as Allele, Genotype and Urology as well as Endocrinology.

His Type 2 diabetes research incorporates themes from Hypoglycemia, Obesity, Surgery, MEDLINE and Intensive care medicine. Stefano Del Prato focuses mostly in the field of Insulin, narrowing it down to topics relating to Carbohydrate metabolism and, in certain cases, Lipotoxicity. His Impaired glucose tolerance study, which is part of a larger body of work in Insulin resistance, is frequently linked to Serum triglycerides, bridging the gap between disciplines.

His most cited work include:

  • Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future (814 citations)
  • How Do We Define Cure of Diabetes (661 citations)
  • Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes (638 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of investigation include Internal medicine, Diabetes mellitus, Endocrinology, Type 2 diabetes and Insulin. Stefano Del Prato studies Internal medicine, namely Insulin resistance. His research integrates issues of Obesity, Surgery, MEDLINE and Intensive care medicine in his study of Diabetes mellitus.

His work is connected to Metabolic syndrome, Pancreatic islets, Carbohydrate metabolism, Albuminuria and Islet, as a part of Endocrinology. His Type 2 diabetes study integrates concerns from other disciplines, such as Metformin, Randomized controlled trial, Glycemic and Disease. Insulin is represented through his Basal, Insulin oscillation and Postprandial research.

He most often published in these fields:

  • Internal medicine (61.40%)
  • Diabetes mellitus (43.52%)
  • Endocrinology (39.64%)

What were the highlights of his more recent work (between 2017-2021)?

  • Internal medicine (61.40%)
  • Type 2 diabetes (32.38%)
  • Diabetes mellitus (43.52%)

In recent papers he was focusing on the following fields of study:

Stefano Del Prato mainly focuses on Internal medicine, Type 2 diabetes, Diabetes mellitus, Metformin and Intensive care medicine. His studies in Internal medicine integrate themes in fields like Gastroenterology, Placebo and Type 1 diabetes. His biological study spans a wide range of topics, including Randomized controlled trial, Glycemic, Combination therapy and Glucagon-like peptide 1 receptor.

His research integrates issues of Obesity, Insulin, MEDLINE and Renal function in his study of Diabetes mellitus. His Metformin study necessitates a more in-depth grasp of Endocrinology. Stefano Del Prato mostly deals with Body mass index in his studies of Endocrinology.

Between 2017 and 2021, his most popular works were:

  • Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial (555 citations)
  • COVID-19 in people with diabetes: understanding the reasons for worse outcomes. (204 citations)
  • New-Onset Diabetes in Covid-19. (173 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Diabetes mellitus
  • Type 2 diabetes

His primary areas of study are Diabetes mellitus, Internal medicine, Type 2 diabetes, Placebo and Hazard ratio. The various areas that Stefano Del Prato examines in his Diabetes mellitus study include Severity of illness, Obesity, Increased risk and Pneumonia. His Internal medicine research includes elements of Gastroenterology and Type 2 Diabetes Mellitus.

His Type 2 diabetes research includes themes of Metformin, Intensive care medicine and Urology. His Metformin study is related to the wider topic of Endocrinology. His Endocrinology study combines topics from a wide range of disciplines, such as Cognition and Sensory processing, Sensory system.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future

Steven E Kahn;Mark E Cooper;Stefano Del Prato.
The Lancet (2014)

1382 Citations

How Do We Define Cure of Diabetes

John B. Buse;Sonia Caprio;William T. Cefalu;Antonio Ceriello.
Diabetes Care (2009)

1042 Citations

Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes

Valeriya Lyssenko;Roberto Lupi;Piero Marchetti;Silvia Del Guerra.
Journal of Clinical Investigation (2007)

927 Citations

Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: a Joint Statement by International Diabetes Organizations.

Francesco Rubino;David M Nathan;Robert H Eckel;Philip R Schauer.
Obesity Surgery (2017)

836 Citations

Prolonged Exposure to Free Fatty Acids Has Cytostatic and Pro-Apoptotic Effects on Human Pancreatic Islets: Evidence that β-Cell Death Is Caspase Mediated, Partially Dependent on Ceramide Pathway, and Bcl-2 Regulated

Roberto Lupi;Francesco Dotta;Lorella Marselli;Silvia Del Guerra.
Diabetes (2002)

828 Citations

Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations

Francesco Rubino;David M. Nathan;Robert H. Eckel;Philip R. Schauer.
Diabetes Care (2016)

711 Citations

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F Hernandez;Jennifer B Green;Salim Janmohamed;Ralph B D'Agostino.
The Lancet (2018)

640 Citations

Dapagliflozin Versus Glipizide as Add-on Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control With Metformin: A randomized, 52-week, double-blind, active-controlled noninferiority trial

Michael A. Nauck;Stefano Del Prato;Juris J. Meier;Santiago Durán-García.
Diabetes Care (2011)

622 Citations

Management of type 2 diabetes: new and future developments in treatment.

Abd A Tahrani;Abd A Tahrani;Clifford J Bailey;Stefano Del Prato;Anthony H Barnett;Anthony H Barnett.
The Lancet (2011)

583 Citations

Coxsackie B4 virus infection of β cells and natural killer cell insulitis in recent-onset type 1 diabetic patients

Francesco Dotta;Stefano Censini;Astrid G. S. van Halteren;Lorella Marselli.
Proceedings of the National Academy of Sciences of the United States of America (2007)

559 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Stefano Del Prato

Piero Marchetti

Piero Marchetti

University of Pisa

Publications: 140

Leif Groop

Leif Groop

Lund University

Publications: 88

Ralph A. DeFronzo

Ralph A. DeFronzo

The University of Texas Health Science Center at San Antonio

Publications: 82

Carel W. le Roux

Carel W. le Roux

University College Dublin

Publications: 66

Geltrude Mingrone

Geltrude Mingrone

King's College London

Publications: 54

Decio L. Eizirik

Decio L. Eizirik

Université Libre de Bruxelles

Publications: 54

Angelo Avogaro

Angelo Avogaro

University of Padua

Publications: 52

André Scheen

André Scheen

University of Liège

Publications: 51

Guy A. Rutter

Guy A. Rutter

Imperial College London

Publications: 50

Kamlesh Khunti

Kamlesh Khunti

University of Leicester

Publications: 49

Mark I. McCarthy

Mark I. McCarthy

University of Oxford

Publications: 47

Giorgio Sesti

Giorgio Sesti

Sapienza University of Rome

Publications: 44

Antonio Ceriello

Antonio Ceriello

University of Barcelona

Publications: 39

Philippe Froguel

Philippe Froguel

Imperial College London

Publications: 39

Jens J. Holst

Jens J. Holst

University of Copenhagen

Publications: 35

Michael A. Nauck

Michael A. Nauck

Ruhr University Bochum

Publications: 35

Trending Scientists

Arkady Glukhovsky

Arkady Glukhovsky

Given Imaging (Germany)

Kenneth R. Foster

Kenneth R. Foster

University of Pennsylvania

Yujie Feng

Yujie Feng

Harbin Institute of Technology

Huogen Yu

Huogen Yu

Wuhan University of Technology

Anil V. Virkar

Anil V. Virkar

University of Utah

Bernard F. Erlanger

Bernard F. Erlanger

Columbia University

Michael R. Gold

Michael R. Gold

University of British Columbia

Isabelle Manighetti

Isabelle Manighetti

Centre national de la recherche scientifique, CNRS

Takayuki Ushikubo

Takayuki Ushikubo

Japan Agency for Marine-Earth Science and Technology

Philipp Kanske

Philipp Kanske

TU Dresden

John D. Van Horn

John D. Van Horn

University of Virginia

Darrell A. Henze

Darrell A. Henze

MSD (United States)

Lee J. Cronbach

Lee J. Cronbach

Stanford University

Clark L. Hull

Clark L. Hull

Yale University

Kenneth J. Gergen

Kenneth J. Gergen

Swarthmore College

David G. Beer

David G. Beer

University of Michigan–Ann Arbor

Something went wrong. Please try again later.